1. Home
  2. NEPH

as 07-26-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.

Founded: 1997 Country:
United States
United States
Employees: N/A City: SOUTH ORANGE
Market Cap: 22.2M IPO Year: 2004
Target Price: $5.00 AVG Volume (30 days): 9.5K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.14 EPS Growth: N/A
52 Week Low/High: $1.35 - $4.04 Next Earning Date: 08-07-2024
Revenue: $14,063,000 Revenue Growth: 22.14%
Revenue Growth (this year): 14.55% Revenue Growth (next year): 12.91%

NEPH Daily Stock ML Predictions

Stock Insider Trading Activity of Nephros Inc. (NEPH)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Amron Arthur H NEPH Director May 28 '24 Buy $2.22 2,000 $4,441.40 100,463 SEC Form 4
Amron Arthur H NEPH Director May 28 '24 Buy $2.24 3,000 $6,734.70 103,463 SEC Form 4
Banks Robert R. Jr. NEPH President and CEO May 14 '24 Buy $2.24 50,000 $112,050.00 70,000 SEC Form 4
Amron Arthur H NEPH Director Mar 12 '24 Buy $2.45 7,000 $17,129.70 7,000 SEC Form 4
Banks Robert R. Jr. NEPH President and CEO Dec 7 '23 Buy $2.20 18,000 $39,646.80 20,000 SEC Form 4

Share on Social Networks: